Open original FDA record ↗Recall record
- FDA identifier
- Z-2005-2008
- Company in FDA record
- Medtronic International Trade Inc
- FDA classification date
- Jul 30, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Medtronic is advising that certain Trillium-coated Medtronic cardiopulmonary bypass (CBP) products (e.g., oxygenators, reservoirs, pumps and tubing packs) were manufactured with heparin batches contaminated with oversulfated chondroitin sulfate (OSCS). Based upon currently available information, Medtronic has determined that Medtronic Trillium-coated products can continue to be used in cardiopulm
Source facts
- Action
- Medtronic Cardiovascular Customers were sent the May 05, 2008 Urgent Medical Device Corrective Action letter to advise them that certain Trillium-coated cardiopulmonary bypass products were manufactured with heparin which may be contaminated with oversulfated chondroitin sulfate. The letter discussed the risk evaluation and gave recommendations to healthcare professionals for patient care. Affected devices can continue to be used in cardiopulmonary bypass procedures.
- Initiated
- 2008-05-07
- Root cause
- Nonconforming Material/Component
- Terminated
- 2008-12-01
- Distribution
- Worldwide Distribution, including USA.
- Recall number
- Z-2005-2008
- Recall status
- Terminated
- CDRH record ID
- 70837
- FDA classified
- 2008-07-30
- Recall event number
- 48101